HEALTHglobal
Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall - Fierce Pharma
Single source
Updated 4 hours ago
First seen March 14, 2026 00:33:42Stay on top of this story
Follow the names and topics behind it.
Add this story's key topics to your watchlist so LyscoNews can highlight related developments and future matches.
Create a free account to sync your watchlist, saved stories, and alerts across devices.
Quick Summary
Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall Fierce Pharma